Pediatric, adult, and therapy-related leukemias are associated with the chromosomal rearrangement at 11q23 that linked the implication of the lysine methyltransferase 2A (KMT2A) gene as a driver in AML [19]. This evidence concerns the gene KMT2A and leukemia.